Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

Published:2016-12-27 Issue:1 Volume:55 Page:729-739
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Molavi Ommoleila¹²³,Narimani Farzaneh²,Asiaee Farshid²,Sharifi Simin²,Tarhriz Vahideh²,Shayanfar Ali²,Hejazi Mohammadsaied²,Lai Raymond³

Affiliation:

1. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

2. Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

3. Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2016.1270972

Reference43 articles.

1. STAT3 as a target for inducing apoptosis in solid and hematological tumors

2. Multiple Drug Resistance Mechanisms in Cancer

3. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy

4. Silibinin – A Promising New Treatment for Cancer

5. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between Dietary Antioxidants, Dietary Fiber and the Gut Microbiome: Their Putative Role in Inflammation and Cancer;International Journal of Molecular Sciences;2024-07-28

2. Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives;Current Pharmaceutical Biotechnology;2024-06-07

3. Near-Infrared Laser-Responsive Erythrocyte Membrane Camouflaged Nanoparticles for Chemo-Photodynamic Therapy of Breast Cancer;ACS Applied Nano Materials;2024-05-28

4. Preclinical Evidence-based Neuroprotective Potential of Silibinin;Current Drug Research Reviews;2024-03

5. Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells;Biochemistry and Biophysics Reports;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3